Market Cap 2.05B
Revenue (ttm) 423.24M
Net Income (ttm) -43.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 38.50
Profit Margin -10.20%
Debt to Equity Ratio 0.00
Volume 701,547
Avg Vol 821,860
Day's Range N/A - N/A
Shares Out 72.97M
Stochastic %K 27%
Beta 0.06
Analysts Strong Sell
Price Target $37.86

Company Profile

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chron...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 431 9100
Address:
23 Old Bond Street, Floor 3, London, United Kingdom
Doozio
Doozio Jun. 28 at 1:43 PM
$KNSA 3wt at da $$$$$
0 · Reply
RonIsWrong
RonIsWrong Jun. 21 at 3:10 AM
$KNSA holding the line. weekly chart
0 · Reply
Chomo
Chomo Jun. 12 at 10:23 PM
$KNSA sold at 2020 high level (green line) on high volume.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jun. 8 at 10:44 PM
$KNSA $2.11B mc founder-led $XBI name sneaking in an ATH weekly close above freshly rising 10/40/80-week SMAs. 8-year cup-and-handle, picture perfect volume profile - Short squeeze under way with short float % having cratered from 30%+ to now sub 10% over the past year - Pct of all funds long is knocking on ATHs after a jump in the most recent qtr TrendEdge.app/asset/KNSA
0 · Reply
Doozio
Doozio Jun. 7 at 3:49 PM
$KNSA da huckleberries are thru da $$$$ in a text book $$$$$ pattern.
0 · Reply
RonIsWrong
RonIsWrong Jun. 6 at 8:10 PM
$KNSA nice close! pushed out of that bull flag I posted earlier
1 · Reply
RonIsWrong
RonIsWrong Jun. 5 at 5:27 PM
$KNSA hmmm
1 · Reply
briefingcom
briefingcom Jun. 5 at 11:59 AM
Gapping Down: $BARK -9.2% $PVH -8.9% $WGO -8.4% $CIEN -4.9% $KNSA -2.2%
0 · Reply
RonIsWrong
RonIsWrong Jun. 3 at 3:33 PM
$KNSA weekly
1 · Reply
RonIsWrong
RonIsWrong Jun. 3 at 3:28 PM
$KNSA strong breakout. highest stock price since ... 2018!
0 · Reply
Latest News on KNSA
Kiniksa Pharmaceuticals: Making Steady Progress

May 5, 2025, 4:51 PM EDT - 2 months ago

Kiniksa Pharmaceuticals: Making Steady Progress


Big Pipeline Updates From Kiniksa Pharmaceuticals

Feb 25, 2025, 4:14 PM EST - 4 months ago

Big Pipeline Updates From Kiniksa Pharmaceuticals


Kiniksa Pharmaceuticals Provides Corporate Update

Jan 4, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Provides Corporate Update


Kiniksa Pharmaceuticals: Arcalyst's Growth Picks Up

Jul 27, 2023, 10:57 AM EDT - 2 years ago

Kiniksa Pharmaceuticals: Arcalyst's Growth Picks Up


Kiniksa Pharmaceuticals: A Somewhat Complicated Story

Jun 9, 2023, 12:32 PM EDT - 2 years ago

Kiniksa Pharmaceuticals: A Somewhat Complicated Story


Doozio
Doozio Jun. 28 at 1:43 PM
$KNSA 3wt at da $$$$$
0 · Reply
RonIsWrong
RonIsWrong Jun. 21 at 3:10 AM
$KNSA holding the line. weekly chart
0 · Reply
Chomo
Chomo Jun. 12 at 10:23 PM
$KNSA sold at 2020 high level (green line) on high volume.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jun. 8 at 10:44 PM
$KNSA $2.11B mc founder-led $XBI name sneaking in an ATH weekly close above freshly rising 10/40/80-week SMAs. 8-year cup-and-handle, picture perfect volume profile - Short squeeze under way with short float % having cratered from 30%+ to now sub 10% over the past year - Pct of all funds long is knocking on ATHs after a jump in the most recent qtr TrendEdge.app/asset/KNSA
0 · Reply
Doozio
Doozio Jun. 7 at 3:49 PM
$KNSA da huckleberries are thru da $$$$ in a text book $$$$$ pattern.
0 · Reply
RonIsWrong
RonIsWrong Jun. 6 at 8:10 PM
$KNSA nice close! pushed out of that bull flag I posted earlier
1 · Reply
RonIsWrong
RonIsWrong Jun. 5 at 5:27 PM
$KNSA hmmm
1 · Reply
briefingcom
briefingcom Jun. 5 at 11:59 AM
Gapping Down: $BARK -9.2% $PVH -8.9% $WGO -8.4% $CIEN -4.9% $KNSA -2.2%
0 · Reply
RonIsWrong
RonIsWrong Jun. 3 at 3:33 PM
$KNSA weekly
1 · Reply
RonIsWrong
RonIsWrong Jun. 3 at 3:28 PM
$KNSA strong breakout. highest stock price since ... 2018!
0 · Reply
RonIsWrong
RonIsWrong Jun. 3 at 2:18 PM
$KNSA 👀
0 · Reply
Happy_Feet19
Happy_Feet19 Jun. 2 at 11:29 PM
$KNSA Why are we still on the acquisition market? We have insane sales. Projected sales volume for a potential Buyout evaluation given by company. We only have a small pipeline (1 pet project that is years away from any meanifull value added). So why are we not getting swamped with BO offers?
1 · Reply
Doozio
Doozio Jun. 2 at 5:44 PM
$KNSA is ready to $ASND thru da $$$ pattern with da huckleberries as $XBI bahhhhhhtoms!!!
0 · Reply
reallysure55
reallysure55 Jun. 1 at 2:06 PM
$KNSA ,does follow this company
0 · Reply
Doozio
Doozio May. 22 at 10:48 PM
$KNSA nice TTWO see YO here! 🍿
0 · Reply
Doozio
Doozio May. 22 at 9:48 PM
$TIL Roger is rocking and $KNSA takes those huckleberries thru da $$$$ INTA 🐒🍌🧠⏰♾️
0 · Reply
RonIsWrong
RonIsWrong May. 18 at 7:30 PM
Great post and data illustration by @clownmarket! Gracias! Note that $TARS XDEMVY is having the best trajectory of all of these so far. Approved in late July 2023, the first full quarter was this Q4 '23. $BCRX $TGTX $KNSA $AUPH
3 · Reply
BioAmerica
BioAmerica May. 13 at 10:52 AM
$BCRX $TGTX $KNSA $AUPH $SWTX I think you are looking at the wrong end of the chart. You should be paying the most attention to the vertical date lines, and compare where each was at a certain point in time from the date of launch. That shows a much different story. With these companies, I think the 5 quarter line is a fair comparison. Note that at five quarters, nobody was over $50MM, four were right at $50MM, and one was at $50, but at only 4 quarters. Move out to 10 quarters and we see four companies, and three of those four were the three worst at the 5 quarter mark. My take on the results? It will take two to three years reach a full potential growth. This is why that one to three year period is the time for BP to jump in and take over.
0 · Reply
clownmarket
clownmarket May. 13 at 10:31 AM
$BCRX $TGTX $KNSA $AUPH $SWTX AUPH reported yesterday so I can post the updated chart for Q1. The IOVA rugpull has been discussed enough and ARDX's Ibsrela surprised with disappointing revenue, but their Xphoxazh drug was expected to drop off due to the Medicare/TDAPA issues so that wasn't a demand problem at all The most interesting story here - not as discussed as the others - is the Ogsiveo revenue given the recent BO which disappointed everyone. But their earnings showed a sharp slowdown in Q1 which is more than should be the case for early launch even accounting for typical Q1 headwinds. This frames the negotiations with German Merck in a completely different light with SWTX in a weaker position than people assumed TGTX dropped after earnings but you can see the Briumvi trajectory remains very strong - I think it was just a valuation issue, at 7Bn mc (same as MDGL) before earnings. Arcalyst and Orladeyo both continue to accelerate revenue growth
3 · Reply
RonIsWrong
RonIsWrong May. 13 at 4:19 AM
$KNSA what a move. missed it completely unfortunately, but happy to see it nonetheless. holding up nicely here for now. let's see how the next few days turn out, and if it sets a bullish pattern for further action.
2 · Reply
Doozio
Doozio May. 10 at 3:16 PM
$KNSA chop chop huckleberries out of 🐑⏰♾️ INTA 🐒🍌🧠⏰♾️. YUGE potential.
0 · Reply
briefingcom
briefingcom May. 6 at 1:30 PM
Emerging Growth: ODDITY is a new member of our GROWX rankings this week. $ODD is a digital-first beauty and wellness company and its goal is to disrupt the offline-dominated beauty and wellness industries. ODD says the beauty industry is transforming and the company is well-positioned to benefit. ODD should benefit from two trends: consumers moving online and towards high-performance products. While brick-and-mortar brands navigate weak store performance against volatile demand, ODD says its business is benefiting from a powerful shift online. Other additions this week include: $KNSA $HIMS $SEZL $NEXN https://briefing.com/todays-free-feature?utm_campaign=freefeature&utm_medium=social&utm_source=st&utm_content=link #smallcap #midcap #stocks #top100 #growthstocks #stockanalysis #TodaysFreeFeature
0 · Reply